Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-9.91%
+14.62%
-1.42%
+1.44%
+3.52%
HOLX
Hologic
$73.94
Strengths
Trading below its fair value
Investors confidence is positive
Upgraded on attractively valued
Risk Analysis
Earnings are forecast to decrease
Technical Indicators
MACD above signal line
Chart
$65.79 (+12.39%)
$64.98 (+13.79%)
$62.01 (+19.24%)
$78.8 (-6.17%)
HOLX has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
HOLX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Has a Strong balance sheet
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Investors confidence is positive
Future
Future
Trading below its fair value
Earnings are forecast to decrease
HOLX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
HOLX Street view is extremely bullish but have mixed views on the near-term outlook
Average key support and resistance price levels.
HOLX Earnings
The TTM reflects 12-month period, providing review of HOLX financial performance.
The company financial health has shown minor improvement, but significant issues remain
Financial Score
What is HOLX current stock price?
What are HOLX stock strengths?
What risks are associated with HOLX stock?
When is HOLX next earnings report?
What is HOLX market cap and volume?
What is HOLX's current Stock IQ?
Should I buy HOLX stock right now?
Is HOLX a Strong Buy right now?
What does a 'Strong Buy' rating mean for HOLX?
What does a 'Strong Sell' rating mean for HOLX?
What factors influence HOLX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-9.91%
+14.62%
-1.42%
+1.44%
+3.52%
HOLX
Hologic
Current Price
$73.94
Stock Insights
Strengths
Trading below its fair value
Investors confidence is positive
Upgraded on attractively valued
Risk Analysis
Earnings are forecast to decrease
Technical Indicators
MACD above signal line
Chart
$65.79 (+12.39%)
$64.98 (+13.79%)
$62.01 (+19.24%)
$78.8 (-6.17%)
HOLX Analysts Opinion
HOLX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Has a Strong balance sheet
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Investors confidence is positive
Future
Future
Trading below its fair value
Earnings are forecast to decrease
HOLX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
HOLX Street view is extremely bullish but have mixed views on the near-term outlook
HOLX has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Average key support and resistance price levels.
HOLX Earnings
The TTM data reflects the most recent 12-month period, providing overview of HOLX financial performance.
HOLX Financial Health
The company financial health has shown minor improvement, but significant issues remain
Financial Score
HOLX Latest Analysis
Needham Reiterates Hologic (HOLX) Hold Recommendation. Fintel reports that on October 21 2025 Needham reiterated coverage of Hologic (NasdaqGS:HOLX) with a Hold recommendation. Analyst Price Forecast Suggests 0.73% Downside
Today
BTIG Reiterates Hologic (HOLX) Neutral Recommendation. Fintel reports that on October 21 2025 BTIG reiterated coverage of Hologic (NasdaqGS:HOLX) with a Neutral recommendation. Analyst Price Forecast Suggests 0.73% Downside
Today
Buy Hold or Sell Hologic Stock? Key Insights Ahead of Q4 Earnings. HOLXs fiscal Q4 2025 earnings may face limits as macro pressures and slow Diagnostics curb momentum.
Mon Oct 20, 2025
Hologic ticks higher amid report on financing for potential takeover.
Thu Oct 16, 2025
Is Most-Watched Stock Hologic Inc. (HOLX) Worth Betting on Now?. Recently Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Tue Oct 14, 2025
Hologic Expands Panther Fusions Menu With Diagnostic Innovation. HOLX expands its Panther Fusion platform with new GI bacterial assays securing FDA and EU approvals to boost Diagnostics growth.
Wed Oct 8, 2025
Hologic upgraded at Evercore ISI on growth turnaround.
Tue Oct 7, 2025
How to Play HOLX Stock This Breast Cancer Awareness Month?. Hologics breast health innovations AI breakthroughs and leadership moves signal optimism ahead despite macro headwinds.
Mon Oct 6, 2025
HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests. Hologics shares rise after receiving FDA clearance and CE mark for its rapid molecular GI assays on the Panther Fusion platform.
Fri Oct 3, 2025
Why Hologic (HOLX) Outpaced the Stock Market Today. In the closing of the recent trading day Hologic (HOLX) stood at $67.91 denoting a 1.3% move from the preceding trading day.
Thu Oct 2, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
HOLX Stock trends
HOLX Stock performance
HOLX Stock analysis
HOLX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.